Short Communication - (2016) Volume 7, Issue 2

A Novel Anti-cancer Strategy Targeting CD44-positive Cancer Stem Cells

Seishima R1,2, Okabayashi K1*, Nagano O2, Hasegawa H1, Tsuruta M1, Saya H2 and Kitagawa Y1
1Department of Surgery, Keio University School of Medicine, 35 Shinano-machi, Shinjuku-ku, Tokyo 1608582, Japan
2Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinano-machi, Shinjuku-ku, Tokyo 1608582, Japan
*Corresponding Author: